2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs.
10.3760/cma.j.cn112148-20200308-00171
- Author:
Hao Zhe SHI
1
;
Ping MA
1
;
Feng Ying GAO
1
;
Gong Lie CHEN
1
;
Yu Hui WANG
1
;
Xun De XIAN
1
;
Er Dan DONG
2
Author Information
1. Institute of Cardiovascular Sciences, Peking University Health Science Center, Beijing 100191, China.
2. Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides of National Health Commision, Key Laboratory of Molecular Cardiovascular Science of Ministry of Education, Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100191, China.
- Publication Type:Journal Article
- MeSH:
Angiotensin Receptor Antagonists;
Angiotensin-Converting Enzyme 2;
Betacoronavirus;
COVID-19;
Cardiovascular Agents/pharmacology*;
Cardiovascular Diseases;
Coronavirus Infections/physiopathology*;
Humans;
Pandemics;
Peptidyl-Dipeptidase A/physiology*;
Pneumonia, Viral/physiopathology*;
SARS-CoV-2
- From:
Chinese Journal of Cardiology
2020;48(7):532-538
- CountryChina
- Language:Chinese
